N-[5-TRIFLUOROMETHYL-3-(4-METHOXYPHENYL)-CARBONYLOXY-1-PHENYL-1H-PYRAZOL-4-YL]-N-METHYL-4-METHOXY-BENZAMIDE
Compound with spectra: 1 NMR
![N-[5-TRIFLUOROMETHYL-3-(4-METHOXYPHENYL)-CARBONYLOXY-1-PHENYL-1H-PYRAZOL-4-YL]-N-METHYL-4-METHOXY-BENZAMIDE](/api/compound/9sTqHRRoAL8.png?ph=true&h=300&w=458 "N-[5-TRIFLUOROMETHYL-3-(4-METHOXYPHENYL)-CARBONYLOXY-1-PHENYL-1H-PYRAZOL-4-YL]-N-METHYL-4-METHOXY-BENZAMIDE")
| SpectraBase Compound ID | 9sTqHRRoAL8 |
|---|---|
| InChI | InChI=1S/C27H22F3N3O5/c1-32(25(34)17-9-13-20(36-2)14-10-17)22-23(27(28,29)30)33(19-7-5-4-6-8-19)31-24(22)38-26(35)18-11-15-21(37-3)16-12-18/h4-16H,1-3H3 |
| InChIKey | PXHPMVNHFWZGAV-UHFFFAOYSA-N |
| Mol Weight | 525.48 g/mol |
| Molecular Formula | C27H22F3N3O5 |
| Exact Mass | 525.151155 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-(3-BENZOYLOXY-5-TRIFLUOROMETHYL-1-PHENYL-1H-PYRAZOL-4-YL)-N-METHYL-BENZAMIDE
N-(5-BENZOYLOXY-3-TRIFLUOROMETHYL-1-PHENYL-1H-PYRAZOL-4-YL)-N-METHYL-BENZAMIDE
(3-benzoyl-1,5-diphenyl-4-pyrazolyl)-phenylmethanone
Morpholine, 4-[1-(4-fluorophenyl)-4,5-dihydro-5-methyl-2,5-diphenyl-1H-imidazol-4 -yl]-
7-(difluoromethyl)-N-[3,5-dimethyl-1-(4-methylbenzyl)-1H-pyrazol-4-yl]-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
3-(1,3-benzodioxol-5-yl)-7-isopropoxy-2-methyl-6-propyl-4H-chromen-4-one
6-HYDROXY-3,3-DIMETHYLPYRANO-[2,3-C]-XANTHEN-7(3H)-ONE
6,6-dimethyl-2-phenyl-3-(3-pyridinyl)-2,5,6,7-tetrahydro-4H-indazol-4-one
11-AMINO-1,2,3,4,7,8,9,10-OCTAHYDRO-[1]-BENZOTHIENO-[2,3-B]-QUINOLINE
3-thiophenecarboxylic acid, 2-[(1,3-benzodioxol-5-ylcarbonyl)amino]-5-[[[2-(ethoxycarbonyl)phenyl]amino]carbonyl]-4-methyl-, ethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Trifluoromethyl-Substituted Pyrazoles and 1,2,4-Triazines by Ring Transformation of Mesoionic 4-Trifluoroacetyl-1,3-oxazolium-5-olates with Phenylhydrazine | Chemical and Pharmaceutical Bulletin | 2008 |